AstraZeneca, Oxford coronavirus vaccine trial can continue in the US - Business Insider
1 min read
AstraZeneca and the University of Oxford to resume late-stage trials for a COVID-19 vaccine in the US.
AstraZeneca and the University of Oxford's coronavirus vaccine trials can continue in the US, The Wall Street Journal reported.

The late-stage trial had paused September 6 after AstraZeneca reported "suspected serious adverse reaction" in a UK-based participant.

The UK resumed clinical trials for AstraZeneca and the University of Oxford vaccines in September, and in Japan earlier this month.

Visit Business Insider's homepage for more stories.

The US has allowed a major coronavirus vaccine trial to resume.

The Food and Drug Administration has…
Allana Akhtar
Read full article